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Background: Azadirachta indica is widely distributed in Africa, Asia and other tropical parts of the world.
A. indica (AI) is traditionally used for the treatment of several conditions including cancer, hypertension,
heart diseases and skin disorders. Intestinal ischaemia-reperfusion is a common pathway for many
diseases and may lead to multiple organ dysfunction syndrome and death.
Objective: In this study, we investigated the ameliorative effects of AI on intestinal ischaemia-reperfusion
injury-induced cardiorenal dysfunction.
Materials and methods: Sixty rats were divided into 6 groups; each containing 10. Corn oil was orally
administered to group A (control) rats for 7 days without intestinal ischaemia-reperfusion injury. Group
B underwent intestinal ischaemia-reperfusion injury (IIRI) without any pre-treatment. Groups C, D, E and
F were pre-treated orally for 7 days with 100 mg/kg AI (100 and (200 mg/kg) vitamin C (100 and 200 mg/
kg) respectively and thereafter underwent IIRI on the 8th day.
Results: The cardiac and renal hydrogen peroxide increased signiﬁcantly whereas serum xanthine oxi-
dase and myeloperoxidase levels were signiﬁcantly elevated (p < 0.05) in IIRI only when compared to the
control. The cardiac and renal reduced glutathione, glutathione peroxidase, protein thiol, non-protein
thiol and serum nitric oxide (NO) decreased (p < 0.05) signiﬁcantly following IIRI. Immunohistochem-
ical evaluation of cardiac and renal tissues showed reduced expressions of the extracellular signal
regulated kinase (ERK1/2) in rats with IIRI only. However, pre-treatment with A. indica and vitamin C
signiﬁcantly reduced markers of oxidative stress and inﬂammation together with improvement in
antioxidant status. Also, reduced serum NO level was normalised in rats pre-treated with A. indica and
vitamin C with concomitant higher expressions of cardiac and renal ERK1/2.
Conclusions: Together, A. indica and vitamin C prevented IRI-induced cardiorenal dysfunction via
reduction in oxidative stress, improvement in antioxidant defence system and increase in the ERK1/2
expressions. Therefore, A. indica can be a useful chemopreventive agent in the prevention and treatment
of conditions associated with intestinal ischaemia-reperfusion injury.
© 2016 Transdisciplinary University, Bangalore and World Ayurveda Foundation. Publishing Services by
Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).(A.A. Oyagbemi).
ary University, Bangalore.
alore and World Ayurveda Found
censes/by-nc-nd/4.0/).1. Introduction
Intestinal ischaemia results from any condition which leads to
arterial occlusion by embolism or thrombi [1,2]. It may also be the
sequelae of non-occlusive processes as is found in conditions causing
lowmesenteric blood ﬂow like cardiac insufﬁciency and sepsis [3,4].ation. Publishing Services by Elsevier B.V. This is an open access article under the
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bacterial translocation, systemic inﬂammatory response syndrome
and reperfusion injury [5]. In order to prevent irreversible damage to
an ischaemic organ, restoration of blood ﬂow is essential, however;
reperfusion may accentuate the injury produced by ischaemia alone
[6e8]. Cellular damage caused by the reperfusion of a previously
viable ischaemic tissue is deﬁned as ischaemia-reperfusion injury
[9]. This reperfusion injury exacerbates the ischaemic damage of the
intestinalmicrocirculation togetherwith a negative outcome [10,11].
Reperfusion of splanchnic arteries following occlusion may precipi-
tate circulatory shock with the consequent activation and adhesion
of polymorphonuclear neutrophils, release of proinﬂammatory
substances and formation of both oxidative and nitrosative stress
[12e14]. Intestinal ischaemia-reperfusion is a common pathway for
manydiseases andmay lead tomultiple organdysfunctionanddeath
[15]. In humans, thrombosis of the mesenteric venous vessels can
result in haemorrhagic infarction with acute mesenteric ischaemia
and irreversible severe tissue pathology [16e18]. Complex in-
teractions between the endothelium and several cell types can be
provoked by ischaemia-reperfusion with resultant microvascular
injury, cellular necrosis and/or apoptosis [19e21]. In severe condi-
tions, resulting inﬂammatory responses from ischaemia-reperfusion
injurymay lead to systemic inﬂammatory response syndrome (SIRS)
and multiple organ dysfunction syndrome (MODS) [22,23]. There-
fore, I-R injurymayextendbeyond the ischaemic area at risk to cause
injury of remote non-ischaemic organs [8].
Azadirachta indica, a plant belonging to the family Meliaceae and
widely distributed in Africa, Asia and other tropical parts of the
world has been extensively utilised in traditional medical practices.
It has been reported that various parts of the plant have various
medicinal and pharmacological properties [24e29] The different
components of A. indica have been indicated to possess antioxidant,
anti-inﬂammatory, anti-proliferative and modulation of various
signalling pathways [28,29]. These properties make A. indica a
therapeutic candidate that can be traditionally used for the treat-
ment of several conditions characterized by free radical generation,
inﬂammatory reactions, cellular proliferations and dysregulation
cellular signalling pathways such as in cancer, hypertension, heart
diseases and skin disorders [31e34]. Intestinal ischaemia-reperfu-
sion injury is a challenging and life-threatening clinical problem
with diverse causes and high mortality rate. With the plethoric ac-
tions and possible beneﬁcial effects of A. indica, we have evaluated
the ameliorative effects and the possiblemechanism of action of the
methanol extract of A. indica and Vitamin C on IIRI- induced car-
diorenal dysfunction and oxidative stress in rats.
2. Materials and methods
2.1. Extraction of plant material
Fresh leaves of A. indica were collected from the Botanical Gar-
den, University of Ibadan and deposited in the herbarium with
voucher number UIH-22527. The leaves were cleaned, air-dried and
crushed into coarse powder using an electric blender. The
powdered leaves were soaked in n-hexane for 72 h and agitated at
intervals, then ﬁltered and afterward soaked in methanol for 24 h
and agitated at intervals. The mixture was ﬁltered thereafter and
ﬁltrate was concentrated in-vacuo at 40 C using a rotary evapo-
rator to give a semi-solid methanol extract of A. indica that was
ﬁnally used for this study.
2.2. Chemicals
Vitamin C, Sulphosalicyclic acid, 2-dichloro-4-nitrobenzene
(CDNB), 5,50-dithio-bis-2-nitrobenzoic acid (DTNB), trichloroaceticacid (TCA), thiobarbituric acid (TBA), reduced glutathione (GSH),
hydrogen peroxide (H2O2), sodium hydroxide (NaOH) pellets,
epinephrine, xylenol orange, Sorbitol, were purchased from Sigma
Aldrich (USA). Normal goat serum, Biotinylated antibody and Horse
Radish Peroxidase (HRP) System was purchased from (KPL, Inc.,
Gaithersburg, Maryland, USA). Extracellular signal regulated kinase
(ERK) antibody was purchased from (Bioss Inc. Woburn, Massa-
chusetts, USA) while 3, 30-Diaminobenzidine (DAB) tablets were
purchased from (AMRESCO LLC. OHio, USA). All other chemicals
usedwereof analytical grade andobtained fromBritishDrugHouses
(Poole, Dorset, UK).
2.3. Experimental animals
Sixty male Wistar rats were obtained from the experimental
animal house of the Faculty of Veterinary Medicine, University of
Ibadan and housed in well-ventilated cages. The rats were fed with
commercial rat chow and water was provided ad libitum. The rats
were subjected to natural photoperiod of about 12 h light and 12 h
darkness daily. The animals were acclimatized for seven (7) days
prior to the commencement of the experiment. The protocols used
were in conformity with the guidelines of the National Institutes of
Health (NIH) guidelines for laboratory animal care and use [35].
2.4. Experimental protocol
The animals were randomly divided into six (6) experimental
groups with ten (10) animals in each group, and the treatment was
as follows:
Group A: Administered with corn oil orally for seven days
without intestinal ischaemia-reperfusion
Group B: Administered with corn oil orally for seven days with
intestinal ischaemia-reperfusion on the 8th day
Group C: Administered with 100 mg/kg body weight of A. indica
orally for seven days with intestinal ischaemia-reperfusion on
the 8th day (AI1)
Group D: Administered with 200 mg/kg body weight A. indica
orally for seven days with intestinal ischaemia-reperfusion on
the 8th day (AI2).
Group E: Administered with 100 mg/kg body weight of vitamin
C orally for seven days and intestinal ischaemia-reperfusion on
the 8th day (Vit C1).
Group F: Administered with 200 mg/kg body weight of vitamin
C orally for seven days and intestinal -reperfusion on the 8th day
(Vit C2).
2.5. Surgical procedure for the induction of intestinal ischaemia-
reperfusion injury
Rats were anaesthetized with Ketamine (90 mg/kg; i.m.) and
Xylazine (10 mg/kg; i.m.). A ventral midline laparotomy was per-
formed after shaving and local cleaning with antiseptic solution. To
induce intestinal ischaemia, the superior mesenteric artery (SMA)
was dissected out and carefully clamped with an atraumatic micro-
vascular clip. Thereafter, the intestines were returned into the
abdomen and the incision was closed temporarily. The clip was
removed following 30 min of occlusion of the SMA and reperfusion
was allowed for 45 min. The animals were thereafter sacriﬁced by
cervical dislocation.
2.6. Serum collection
About 5 ml of blood was collected from the retro-orbital venous
plexus into sterile plain tubes and left for about 30 min to clot. The
Table 1
The effect of A. indica and vitamin C on the level of hydrogen peroxide (H2O2)
generated in cardiac and renal tissues of experimental rats with ischaemia-
reperfusion injury.
Groups Treatment (mg/Kg) H2O2 (heart)
(mmole/mg protein)
H2O2 (kidney)
(mmole/mg protein)
A Control 14.89 ± 0.38 15.29 ± 0.74
B IRI only 16.83 ± 0.65a 20.56 ± 0.14a
C IRI þ AI1 15.89 ± 0.58a,b 18.68 ± 0.76a,b
D IRI þ AI2 16.14 ± 0.14a,b 18.10 ± 0.25a,b
E IRI þ Vit. C1 15.98 ± 0.25a,b 17.04 ± 1.05a,b
F IRI þ Vit C2 15.06 ± 0.58b 17.03 ± 0.69a,b
The results above are shown as Mean ± Standard deviation for each group of eight
(8) rats per group.
IRI ¼ Ischaemia-reperfusion injury; AI1 ¼ Azadirachta indica (100 mg/kg);
AI2 ¼ Azadirachta indica (200 mg/kg); Vit C1 ¼ Vitamin C (100 mg/kg); Vit
C2 ¼ Vitamin C (200 mg/kg).
a p < 0.05 when compared with the corn oil control group.
b p < 0.05 when compared with ischaemia-reperfusion injury group.
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Serumwas decanted into eppendorf tubes and stored at 40 C till
the time of analysis.
2.7. Preparation of tissues for analysis
The blood samples were then centrifuged at 4, 000 rpm for
10 min. The serum was collected and stored in the refrigerator
at 4 C. The heart and kidney tissues were removed, minced with
scissors and homogenized in ice-cold 0.1 M phosphate buffer, pH
7.4. The resultant homogenates were centrifuged at 10, 000 g at 4

C
for 15 min. The post mitochondrial fractions were collected and
processed for biochemical assays.
2.8. Biochemical assays
The post-mitochondrial fractions of the heart and kidneys were
assayed for the estimation of reduced GSH at 412 nm according to
the method by Beutler et al. [36] The Glutathione-S-transferase
(GST) was measured by the method of Habig et al. [37] and gluta-
thione peroxidase (GPx) activity was determined as described by
Rotruck et al. [38] The sulfhydryl (total thiol) and non-protein thiol
(NPT) content was determined as described by Ellman [39]. The
activity of xanthine oxidase (XO) was determined according to
method of Akaike et al. [40] The serum myeloperoxidase (MPO)
activity was determined according to the method of Xia and Zweier
[41]. The malondialdehyde (MDA) level was calculated as described
by Varshney and Kale [42]. Lipid peroxidation in mmol MDA
formed/mg protein as a marker of oxidative stress was computed
with a molar extinction coefﬁcient of 1.56  105 M1cm1.
Hydrogen peroxide generation was estimated as described Wolff
[43]. Nitric oxide (NO) in the serum was measured as earlier
described [44,45]. The concentration of nitrite in the sample was
determined from a sodium nitrite (NaNO2) standard curve and was
expressed as mmol/L. Protein concentration was determined by
Biuret method as described by Gornal et al. [46].
2.9. Immunohistochemistry of cardiac and renal extracellular signal
regulated kinase (ERK)
Immunohistochemistry of parafﬁn embedded tissue of the
heart and kidneys was performed after the tissues were obtained
from buffered formalin perfused rats. Parafﬁn sections were
melted at 60

C in the oven. Dewaxing of the samples in xylene
was followed by passage through ethanol of decreasing concen-
tration (100e80%). Peroxidase quenching in 3% H2O2/methanol
was carried out with subsequent antigen retrieval performed by
microwave heating in 0.01 M citrate buffer (pH 6.0) to boil. All the
sections were blocked in normal goat serum (10%, HistoMark®,
KPL, Gaithersburg MD, USA) and probed with ERK antibody (Bioss,
San Diego, California, USA), 1:300 for 16 h in a refrigerator.
Detection of bound antibody was carried out using biotinylated
(goat anti-rabbit, 2.0 mg/ml) secondary antibody and subsequently,
streptavidin peroxidase (Horse Radish Peroxidase-streptavidin)
according to manufacturer's protocol (HistoMark®, KPL, Gaithers-
burg, MD, USA). Reaction product was enhanced with dia-
minobenzidine (DAB, Amresco®, USA) for 6e10 min and
counterstained with high deﬁnition haematoxylin (Enzo®,
NYeUSA), with subsequent dehydration in ethanol. The slides
were covered with coverslips and sealed with resinous solution.
The immunoreactive positive expression of ERK intensive regions
were viewed starting from low magniﬁcation on each slice then
with 100  magniﬁcations using a photo microscope (Olympus)
and a digital camera (Toupcam®, Touptek Photonics, Zhejiang,
China).2.10. Statistical analysis
All values are expressed as mean ± standard deviation (SD). The
test of signiﬁcance between two groups was estimated by Student's
t-test. One way Analysis of Variance (ANOVA) with Tukey's post-
hoc test using GraphPad Prism 5.0 was also performed with p-
values < 0.05 considered statistically signiﬁcant.
3. Results
3.1. Effect of A. indica and vitamin C on markers of oxidative stress
markers and antioxidant defence system
In Table 1, there was a signiﬁcant (p < 0.05) increase in the
cardiac and renal H2O2 level of rats that underwent ischaemia-
reperfusion injury only when compared to the control. However,
pre-treatment with AI1 (100 mg/kg) and AI2 (200 mg/kg) caused a
signiﬁcant decrease (p < 0.05) in the H2O2 levels when compared
with the rats which underwent IIRI only. Furthermore, a signiﬁcant
(p < 0.05) reduction in the H2O2 levels of the rats pre-treated with
vit C1 (100 mg/kg) and vit C2 (200 mg/kg) was obtained when
compared with the rats that underwent IIRI only (Table 1). Our
study also shows that the rats which underwent ischaemia-
reperfusion injury only, had signiﬁcant (p < 0.05) reduction in the
content of cardiac and renal reduced glutathione (GSH) when
compared to the control (Table 2). Further, pre-treatment with AI1
(100 mg/kg) and AI2 (200 mg/kg) caused a signiﬁcant increase
(p < 0.05) in the GSH content when compared with the rats which
underwent IIRI only. Similarly, there was a signiﬁcant increase
(p < 0.05) in the GSH levels of the groups pre-treated with vit C1
and vit C2 when compared with the rats that underwent IIRI only
(Table 2).
In the heart tissues, there was a signiﬁcant decrease (p < 0.05) in
protein thiol level of rats that underwent IIRI only when compared
with control, while there was a signiﬁcant increase (p < 0.05) in
protein thiol levels of rats pre-treated with AI1 and Vit C1 when
compared with IIRI only (Table 3). In the renal tissues, there was a
signiﬁcant decrease (p < 0.05) in the level of protein thiol of rats
that underwent IIRI only when compared with the control, how-
ever, there was a signiﬁcant increase (p < 0.05) in the rats pre-
treated with AI1, AI2, Vit C1and Vit C2 when compared with the
rats that underwent IIRI only (Table 3). In another experiment,
there was a signiﬁcant decrease (p < 0.05) in non-protein thiol level
in the heart and kidney tissues of rats that underwent IIRI only
when compared to the control while there was a signiﬁcant in-
crease (p < 0.05) in non-protein thiol level in the heart and kidney
Table 2
The effect of A. indica and vitamin C on the level of reduced glutathione (GSH) in the
cardiac and renal tissues of experimental rats with ischaemia-reperfusion injury.
Groups Treatment (mg/Kg) GSH (heart)
(mmole/mg protein)
GSH (kidney)
(mmole/mg protein)
A Control 9.08 ± 1.04 56.33 ± 1.16
B IRI only 7.94 ± 0.13a 53.58 ± 1.26a
C IRI þ AI1 9.19 ± 0.55b 56.75 ± 1.06b
D IRI þ AI2 8.65 ± 0.14b 58.75 ± 1.26a,b
E IRI þ Vit C1 8.75 ± 0.20b 55.96 ± 0.51b
F IRI þ Vit C2 9.00 ± 0.46b 56.40 ± 0.55b
The results above are shown as Mean ± Standard deviation for each group of eight
(8) rats per group.
IRI ¼ Ischaemia-reperfusion injury; AI1 ¼ Azadirachta indica (100 mg/kg);
AI2 ¼ Azadirachta indica (200 mg/kg); Vit C1 ¼ Vitamin C (100 mg/kg); Vit
C2 ¼ Vitamin C (200 mg/kg).
a p < 0.05 when compared with the corn oil control group.
b p < 0.05 when compared with ischaemia-reperfusion injury group.
Table 3
The effect of A. indica and vitamin C on the level of protein thiol (PT) in the cardiac
and renal tissues of experimental rats with ischaemia-reperfusion injury.
Groups Treatment (mg/Kg) PT (heart)
(nmole/mg protein)
PT (kidney)
(nmole/mg protein)
A Control 45.81 ± 3.71 62.19 ± 5.04
B IRI only 34.83 ± 6.58a 56.33 ± 4.40a
C IRI þ AI 1 65.20 ± 7.65a,b 107.92 ± 3.09a,b
D IRI þ AI2 38.54 ± 3.47a 76.00 ± 6.97a,b
E IRI þ Vit C1 42.00 ± 5.22b 67.67 ± 6.78b
F IRI þ Vit C2 38.96 ± 2.09a 67.35 ± 6.80b
The results above are shown as Mean ± Standard deviation for each group of eight
(8) rats per group.
IRI ¼ Ischaemia-reperfusion injury; AI1 ¼ Azadirachta indica (100 mg/kg);
AI2 ¼ Azadirachta indica (200 mg/kg); Vit C1 ¼ Vitamin C (100 mg/kg); Vit
C2 ¼ Vitamin C (200 mg/kg).
a p < 0.05 when compared with the corn oil control group.
b p < 0.05 when compared with ischaemia-reperfusion injury group.
Table 5
The effect of A. indica and vitamin C on the level of glutathione peroxidase (GPx) in
the cardiac and renal tissues of experimental rats with ischaemia-reperfusion injury.
Groups Treatment
(mg/kg)
GPx (heart) (mmole
of GSH/min/mg protein)
GPx (kidney) (mmole of
GSH/min/mg protein)
A Control 141.36 ± 4.77 98.47 ± 6.19
B IRI only 122.47 ± 4.00a 75.82 ± 6.35a
C IRI þ AI1 133.20 ± 6.81a,b 88.83 ± 4.97a,b
D IRI þ AI2 132.33 ± 4.80a,b 100.91 ± 4.03b
E IRI þ Vit C1 136.17 ± 5.01a,b 93.45 ± 2.06a,b
F IRI þ Vit C2 139.55 ± 7.97b 94.06 ± 4.21b
The results above are shown as Mean ± Standard deviation for each group of eight
(8) rats per group.
IRI ¼ Ischaemia-reperfusion injury; AI1 ¼ Azadirachta indica (100 mg/kg);
AI2 ¼ Azadirachta indica (200 mg/kg); Vit C1 ¼ Vitamin C (100 mg/kg); Vit
C2 ¼ Vitamin C (200 mg/kg).
a p < 0.05 when compared with the corn oil control group.
b p < 0.05 when compared with ischaemia-reperfusion injury group.
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when compared with the rats that underwent IIRI only (Table 4).
The activity of renal and cardiac GPx decreased (p < 0.05)
signiﬁcantly in rats that underwent ischaemia-reperfusion injury
only when compared to the control (Table 5). In contrary, pre-
treated of rats with AI1 and AI2 and vit C1 and vit C signiﬁcantly
increased (p < 0.05) the antioxidant activity of GPx when compared
with the rats which underwent IIRI only (Table 5).
In the heart tissues, there was a signiﬁcant increase (p < 0.05) in
the GST level of rats which underwent IIRI only when compared
with control, however, there was a signiﬁcant decrease (p < 0.05) inTable 4
The effect of A. indica and vitamin C on the level of non-protein thiol (NPT) in the
cardiac and renal tissues of experimental rats with ischaemia-reperfusion injury.
Groups Treatment
(mg/Kg)
NPT (heart)
(nmole/mg protein)
NPT (kidney)
(nmole/mg protein)
A Control 94.35 ± 2.50 116.95 ± 3.60
B IRI only 85.15 ± 2.97a 104.92 ± 0.72a
C IRI þ AI1 94.35 ± 7.04b 118.56 ± 2.18b
D IRI þ AI2 89.14 ± 2.81a,b 115.63 ± 5.13b
E IRI þ Vit C1 104.58 ± 9.61a,b 114.50 ± 3.67b
F IRI þ Vit C2 110.63 ± 5.79a,b 127.40 ± 2.04a,b
The results above are shown as Mean ± Standard deviation for each group of eight
(8) rats per group.
IRI ¼ Ischaemia-reperfusion injury; AI1 ¼ Azadirachta indica (100 mg/kg);
AI2 ¼ Azadirachta indica (200 mg/kg); Vit C1 ¼ Vitamin C (100 mg/kg); Vit
C2 ¼ Vitamin C (200 mg/kg).
a p < 0.05 when compared with the corn oil control group.
b p < 0.05 when compared with ischaemia-reperfusion injury group.the GST level of rats thatwere pre-treatedwith AI1, AI2, Vit C1andVit
C2 when compared with the rats that underwent IIRI only (Table 6).
In the kidney tissues, therewas no signiﬁcant difference (p>0.05) in
the GST level of rats that underwent IIRI only and control (Table 6).
However, there was a signiﬁcant (p < 0.05) increase in the rats pre-
treated with AI1, AI2 and Vit C1 when compared with the rats that
underwent IRI only whereas there was no signiﬁcant difference
(p > 0.05) in the rats that were pre-treated with Vit C2 when
compared with the rats that underwent IIRI only (Table 6).3.2. Effect of A. indica and vitamin C on markers of inﬂammation
and renal damage
The result from Table 7 shows that the rats which underwent
ischaemia-reperfusion injury only had signiﬁcantly (p < 0.05)
increased serum level of xanthine oxidase (XO) when compared to
the control. However, a signiﬁcant decrease (p < 0.05) in serum
level of xanthine oxidase (XO) was obtained in the rats pre-treated
with AI1 and AI2 and vit C1 and vit C2 when compared with the rats
which underwent IIRI only (Table 7). The serum level of myelo-
peroxidase (MPO) increased (p < 0.05) signiﬁcantly in rats that
underwent ischaemia-reperfusion injury only when compared to
the control (Table 8) indicating inﬂammation, oxidative stress and
cardiac damage. On the other hand, however, there was a signiﬁ-
cant (p < 0.05) decrease in the levels of myeloperoxidase (MPO) in
the rats pre-treated with AI1 and AI2 and vit C1 and vit C2 when
compared with the rats which underwent IIRI only (Table 8).Table 6
The effect of A. indica and vitamin C on the level of glutathione-S-transferase (GST)
in the cardiac and renal tissues of experimental rats with ischaemia-reperfusion
injury.
Groups Treatment
(mg/Kg)
GST (heart) (mmol
CDNB-GSH complex
formed/min/mg protein)
GST (kidney) (mmol
CDNB-GSH complex
formed/min/mg protein)
A Control 0.739 ± 0.060 1.001 ± 0.373
B IRI only 2.347 ± 0.343a 0.979 ± 0.374
C IRI þ AI1 0.643 ± 0.032a,b 2.388 ± 0.078a,b
D IRI þ AI2 0.696 ± 0.034b 1.695 ± 0.648a,b
E IRI þ Vit C1 0.605 ± 0.083a,b 2.086 ± 0.111a,b
F IRI þ Vit C2 2.010 ± 0.275a,b 1.052 ± 0.438
The results above are shown as Mean ± Standard deviation for each group of eight
(8) rats per group.
IRI ¼ Ischaemia-reperfusion injury; AI1 ¼ Azadirachta indica (100 mg/kg);
AI2 ¼ Azadirachta indica (200 mg/kg); Vit C1 ¼ Vitamin C (100 mg/kg) Vit
C2 ¼ Vitamin C (200 mg/kg).
a p < 0.05 when compared with the corn oil control group.
b p < 0.05 when compared with ischaemia-reperfusion injury group.
Table 7
The effect of A. indica and vitamin C on the level of xanthine oxidase (XO) in the
serum of experimental rats with ischaemia-reperfusion injury.
Groups Treatment group
(mg/kg)
Xanthine oxidase
(serum (mmole/L)
A Control 0.184 ± 0.003
B IRI only 0.224 ± 0.008a
C IRI þ AI1 0.188 ± 0.012b
D IRI þ AI2 0.197 ± 0.004a,b
E IRI þ Vit. C1 0.218 ± 0.001a,b
F IRI þ Vit C2 0.198 ± 0.007a,b
The results above are shown as Mean ± Standard deviation for each group of eight
(8) rats per group.
IRI ¼ Ischaemia-reperfusion injury; AI1 ¼ Azadirachta indica (100 mg/kg);
AI2 ¼ Azadirachta indica (200 mg/kg); Vit C1 ¼ Vitamin C (100 mg/kg); Vit
C2 ¼ Vitamin C (200 mg/kg).
a p < 0.05 when compared with the corn oil control group.
b p < 0.05 when compared with ischaemia-reperfusion injury group.
Table 8
The effect of A. indica and vitamin C on the level of myeloperoxidase (MPO) in the
serum of experimental rats with ischaemia-reperfusion injury.
Groups Treatment group
(mg/kg)
Myeloperoxidase (serum)
(mmole/L)
A Control 11.68 ± 1.13
B IRI only 23.23 ± 0.06a
C IRI þ AI1 11.19 ± 0.56b
D IRI þ AI2 7.57 ± 0.56a,b
E IRI þ Vit. C1 9.76 ± 0.75a,b
F IRI þ Vit C2 13.36 ± 0.77a,b
The results above are shown as Mean ± Standard deviation for each group of eight
(8) rats per group.
IRI ¼ Ischaemia-reperfusion injury; AI1 ¼ Azadirachta indica (100 mg/kg);
AI2 ¼ Azadirachta indica (200 mg/kg); Vit C1 ¼ Vitamin C (100 mg/kg); Vit
C2 ¼ Vitamin C (200 mg/kg).
a p < 0.05 when compared with the corn oil control group.
b p < 0.05 when compared with ischaemia-reperfusion injury group.
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bioavailability as a marker of hypertension
The bioavailability of serum nitric oxide (NO) was taken as a
marker of hypertension in this study. The result shows a signiﬁcant
(p < 0.05) reduction in serum NO level in rats that underwent IIRI
only when compared to the control (Table 9). However, pre-
treatment with AI1 and AI2 and vit C1 and vit C2 caused a signiﬁ-
cant improvement in NO level compared with rats which under-
went IIRI only; which was suggestive of possible anti-hypertensive
effect of AI and Vitamin C (Table 9).Table 9
The effect of A. indica and vitamin C on the level of nitric oxide (NO) in the serum of
experimental rats with ischaemia-reperfusion injury.
Groups Treatment group
(mg/kg)
Serum nitric oxide
(mmole/l)
A Control 0.036 ± 0.007
B IRI only 0.025 ± 0.001a
C IRI þ AI1 0.034 ± 0.004a,b
D IRI þ AI2 0.036 ± 0.006b
E IRI þ Vit. C1 0.042 ± 0.003a,b
F IRI þ Vit C2 0.029 ± 0.006a,b
The results above are shown as Mean ± Standard deviation for each group of eight
(8) rats per group.
IRI ¼ Ischaemia-reperfusion injury; AI1 ¼ Azadirachta indica (100 mg/kg);
AI2 ¼ Azadirachta indica (200 mg/kg); Vit C1 ¼ Vitamin C (100 mg/kg); Vit
C2 ¼ Vitamin C (200 mg/kg).
a p < 0.05 when compared with the corn oil control group.
b p < 0.05 when compared with ischaemia-reperfusion injury group.3.4. Immunohistochemistry of renal and cardiac extracellular signal
regulated kinase (ERK 1/2)
Figs. 1 and 2 show lower expressions of renal and cardiac
Extracellular Signal Regulated Kinase (ERK) expressions compared
to IIRI only. However, higher expressions of ERK were obtained in
rats pre-treated with AI1 and AI2 and vit C1 and vit C2 (Figs. 1 and 2)
respectively.
4. Discussion
Generation of reactive oxygen species (ROS) from oxygen mol-
ecules is one of the factors that causes injury after reperfusion [47].
ROS are derived from the electron transport chain of the mito-
chondria and xanthine oxidase during catabolism of purines [2].
These ROS can overwhelm the antioxidants’ enzymes leading to
oxidative stress which then cause damaging effects to the cells [48].
In this study, intestinal ischaemia-reperfusion caused a signiﬁcant
increase in H2O2 and XOwith a signiﬁcant decrease in GSH levels in
both the heart and kidneys. These effects were reversed in the rats
treated with AI (100 and 200 mg/kg) as well as Vit C (100 and
200 mg/kg) when compared with the controls. This result indicates
the antioxidant and the free radical scavenging activity property of
AI and vitamin C consistent with earlier report of the antioxidant
property of A. indica [49].
The antioxidant properties of AI and vitamin C were further
demonstrated with the signiﬁcant increase in the levels of GSH and
GPx in the heart and kidneys of rats pre-treatedwith AI and vitamin
C. The decreased level of GSH was observed during IIRI which was
probably due to decreased ileal GSH synthesis contributing to its
depletion [50]. The reduced glutathione (GSH) is a non-enzymatic
intracellular antioxidant defence system that participates in
detoxifying H2O2, when it donates its electron to H2O2, reducing it
to H2O and O2. The antioxidant capacity of GSH resides in its sulf-
hydryl (SH) moiety as GHS also protects the cell from lipid perox-
idation by acting as a substrate for GPx and GST [51]. The GPx
catalyses the conversion of H2O2 and other hydroperoxides towater
and oxygen with the help of reduced glutathione (GSH) as a co-
factor. The signiﬁcant increase in the levels of GSH in the AI and
vitamin C pre-treated rats shows the ability of AI and vitamin C to
increase the level of GSH in order to mop up H2O2. Similarly, the
altered levels of GPx in the heart and kidneys due to IIRI were
restored with pre-treatment with AI and vitamin C to a level similar
to that of the control. The alteration in the level of GPx was prob-
ably due to the reduced level of NADPH which is the principal
intracellular reductant, however, pre-treatment with AI and
vitamin C resulted in a signiﬁcant restoration of the G-6-PD activity
as previously reported [52].
Total thiol consists of intracellular and extracellular thiols
which could be in the free form e.g. oxidized and reduced
glutathione or bound to proteins e.g. albumin [53]. The thiol
molecules have been reported to scavenge free radicals and also
play a role in detoxiﬁcation, signal transduction and apoptosis
[54]. Therefore, decreased levels of thiols have been found in
some diseases associated with renal, cardiovascular and several
other organ dysfunction [55]. In this study, IIRI decreased the
level of both protein and non-protein thiols in the kidneys and
heart while AI and vitamin C pre-treatment improved the levels
of the thiols in both the heart and kidneys. This result from the
present study further shows the antioxidant activity of AI. This is
consistent with the reported ability of both AI and vitamins C
which help in the improvement of xenobiotic metabolism and
detoxiﬁcation [56].
In this present study, it was found out that similar to vitamin
C, AI ameliorated oxidative stress induced by IIRI. This was
Fig. 1. Group A (control) shows higher expressions of renal Extracellular Signal Regulated Kinase (ERK 1\2) expressions in the renal tissues. Group B (Ischaemia reperfusion; IRI only)
shows lower expressions of ERK than the control. Group C (IRI þ A. indica (100 mg/kg) shows higher expressions of ERK than Group B. Group D (IRI þ A. indica (200 mg/kg) shows
higher expressions of ERK compared to Group B. Group E (IRI þ Vitamin C (100 mg/kg) shows higher expressions of ERK similar to that of Group A. Group F (IRI þ Vitamin C
(200 mg/kg) shows higher expressions of ERK similar to that of Group A. The slides were counterstained with high deﬁnition haematoxylin and viewed objectives (maginiﬁcation).
Fig. 2. Group A (control) shows higher expressions of Extracellular Signal regulated Kinase (ERK 1/2) expressions in the cardiac tissues. Group B (Ischaemia reperfusion; IRI only)
shows lower expressions of ERK than the control. Group C (IRI þ A. indica (100 mg/kg) shows higher expressions of ERK than Group B. Group D (IRI þ A. indica (200 mg/kg) shows
higher expressions of ERK compared to Group B. Group E (IRI þ Vitamin C (100 mg/kg) shows higher expressions of ERK similar to that of Group A. Group F (IRI þ Vitamin C
(200 mg/kg) shows higher expressions of ERK similar to that of Group A. The slides were counterstained with high deﬁnition haematoxylin and viewed objectives (magniﬁcation).
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oxidase levels in IRI which can contribute to the severe organ
damage observed after reperfusion in ischaemic tissues [57]. In
addition; xanthine oxidase degrades xanthine to uric acid. In the
purine degradation pathway, it oxidizes nicotinamide adenine
dinucleotide (NADH) to generate superoxide anion radical (O2e)
and H2O2 during reperfusion. The increase in serum xanthine
oxidase activity was directly proportional to the serum uric acid
which has been implicated as a biomarker of oxidative stress in
cardiorenal diseases and also a mediator of hypertension [58,59].
Hence, the level of xanthine oxidase in the serum was associated
with IIRI. However, pre-treatment of rats with AI and vitamin C
caused a signiﬁcant reduction in the serum xanthine oxidase
activity normalizing hyperuricaemia (high levels of uric acid in
the blood) which is a diagnostic marker for renal damage and
hypertension.
Similarly, AI and vitamin C also ameliorated the oxidative stress,
inﬂammation and cardiac damage signiﬁed by the decreased level
of myeloperoxidase in the serum of the rats pre-treated with AI and
vitamin C. The MPO catalyses the cycle that produces oxidizing
agents such as HOCl, oxidation of NO and reduction in NO
bioavailability [60]. In patients with cardiovascular diseases, MPO is
usually increased [61]. AI contains important bioactive compounds
which include phytosterols (sitosterols, sigmasterol and campas-
terol) and ﬂavonoids (rutin and quercetin), commonly known for
their antioxidant, anti-inﬂammatory and antimicrobial activities
[62]. Also, consistent with observation is an earlier study in which
AI was reported to decrease the activity of colonic MPO [56]. Since,
AI could normalize the aforementioned elevated MPO, suggesting
AI as an antioxidant, anti-inﬂammatory and cardioprotective
phytonutrient.
In this study, the level of serum NO was reduced following
ischaemia-reperfusion injury. NO has been shown to be a
mediator and/or protector of the vascular systems in several vital
organs including the heart, liver, lungs and kidneys. These pro-
tective actions of nitric oxide in ischaemia-reperfusion injury are
due to its potential as an antioxidant, anti-adhesion, and anti-
inﬂammatory agent [63]. Also, normalization of nitric oxide
bioavailability is an important factor in the amelioration of hy-
pertension by preventing platelet aggregation, improving smooth
muscle relaxation keeping blood vessels patent thereby lowering
blood pressure. However, low levels of NO lead can to imbalance
between dilation and vasoconstriction in favour of constriction
increasing blood pressure with decreased ﬂow leading to hy-
pertension [64]. More importantly, NO may combine with su-
peroxide anion radical to form peroxynitrite (ONOO-) which is a
cytototic agent. The formation of peroxynitrite may also
contribute signiﬁcantly to the reduced bioavailability of NO and
hence to the development of cardiovascular and renal dysfunc-
tion. In this study, AI and Vitamin C ameliorated ischaemia-
reperfusion injury-induced reduction in NO levels in the serum
especially in the rats pre-treated with AI (200 mg/k) and Vit C
(100 mg/kg). However, one of the limitations of the present study
is that we could not take the blood pressure measurement as a
clinical parameter for proper correlation of observable reduced
bioavailability of NO as an indication of hypertensive state.
Furthermore, we endeavour to take this into consideration the
signiﬁcance of this clinical parameter in our future study after
the surgical procedure.
The results in the present study showed that IIRI crashed the
levels of GSH and GPx activity in both the heart and kidneys.
However, IIRI increased the level of GST in the heart. The increase
might be attributable to adaptive responses of cells to oxidative
stress, whereas the pre-treated rats had signiﬁcantly decreased
level of GST. At 200 mg/kg vitamin C, there was a signiﬁcantincrease in the level of GST which was probably due to the ability of
vitamin C to function as pro-oxidants at high concentration [65].
However, in the kidneys; IIRI did not reduce the levels of GST ac-
tivity as the level was similar to that of the control without IIRI.
Meanwhile, AI and vitamin C increased the levels of GST but at
200 mg/kg vitamin C, the level of GST was similar to that IRI only
which might be suggestive of vitamin C as a pro-oxidant at high
concentration. Hence, caution must be exercised in the use of
synthetic antioxidant such as vitamin C and the interpretation of
the results thereof.
The extracellular signal-regulated protein kinases 1 and 2 (ERK
1/2) signalling pathway is a cascade consisting of at least three
families of protein kinases, including Raf (MAPKKK or MEKK),
MAPKKs (MEK1 and MEK2), MAPK (ERK1 and ERK2 or p42/p44
MAPKs). The ERK pathway not only regulates a wide range of
cellular behaviours, such as growth, proliferation, migration, dif-
ferentiation, apoptosis and autophagy, but also mediates inﬂam-
matory responses [66,67]. The ERK pathway can be activated by a
variety of extracellular stimuli such as growth factors, cytokines,
mitogens, hormones and oxidative or heat stress [68]. It has been
demonstrated that activation of ERK 1/2 mediated neuroprotection
of dexmedetomine, a potent and highly selective a2-adrenoceptor
agonist in transient cerebral ischaemia-reperfusion [69]. The acti-
vation of the Reperfusion Injury Salvage Kinase (RISK) pathway,
which incorporates phosphatidylinositol-3-OH kinase (PI3K), AKT/
Protein Kinase B (PKB) and p44/42 Mitogen Activated Protein Ki-
nase (MAPK) underlies protection against IIRI [70]. In the present
study, IIRI reduced the activation of the RISK pathway thereby
reducing the expression of ERK as shown by reduction in the
immuneepositive reaction IRI only group. However, AI and vitamin
C ameliorated tissue damage following IIRI by increasing the ex-
pressions of ERK (a survival protein) as mediated in the RISK
pathway.
The results in the present study have shown that intestinal
ischaemia reperfusion injury does not only have deleterious ef-
fect on the intestines, but also on the heart and kidneys which
was shown by the inhibition of both the enzymic and non-
enzymic antioxidants and increased generation of ROS. Howev-
er, AI was able to ameliorate these deleterious effects by
increasing the in vivo antioxidant status, reduction in markers of
oxidative stress, inﬂammation, cardiac and renal damage
together with improvement in NO bioavailability. Tissue survival
was also mediated via increase in the expressions of ERK.
5. Conclusion
Together, A. indica and vitamin C prevented IRI-induced car-
diorenal dysfunction via reduction in oxidative stress, improve-
ment in antioxidant defence system and increase in the ERK1/2
expressions. Therefore, A. indica can be a useful chemotherapeutic
agent in the prevention and treatment of conditions induced by
intestinal ischaemia-reperfusion injury.
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